Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeutics. Dan Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeutics. Read More »
Synthetic cytokine receptor enables enhanced persistence and next-generation manufacturing of iPSC-derived allogeneic CAR cells Dan Synthetic cytokine receptor enables enhanced persistence and next-generation manufacturing of iPSC-derived allogeneic CAR cells Read More »
A scalable and flexible future for gene therapy production Dan A scalable and flexible future for gene therapy production Read More »
Integrating in vivo Transduction of CARs with Universal Solid Tumor Targeting Molecules Dan Integrating in vivo Transduction of CARs with Universal Solid Tumor Targeting Molecules Read More »
Preclinical Modeling of in vivo Engineered CAR-T Products Dan Preclinical Modeling of in vivo Engineered CAR-T Products Read More »
